Jubilant Ingrevia

₹533 28.2 | 5.6%

WEBSITE BSE:543271 NSE : JUBLINGREA 10 May, 16:01

Market Cap ₹8489 Cr.

Stock P/E 41.0

P/B 3.1

Current Price ₹533

Book Value ₹ 171.9

Face Value 1

52W High ₹581.8

Dividend Yield 0.94%

52W Low ₹ 379.2

Edit Ratio

Jubilant Ingrevia Research see more...

Equity Research: Jubilant Ingrevia Limited

Overview Inc. Year: 2019Industry: Chemicals

Jubilant Ingrevia Ltd offers life science product and its solutions in India and across the world. It operates in 3 segments: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Speciality Chemicals section gives speciality substances, fine chemicals, crop safety chemical substances, and custom improvement and production services. The Nutrition & Health Solutions segment gives nutrients and fitness ingredients, animal nutrients and fitness solutions, and human nutrients and fitness solutions. The Life Science Chemicals offers life science ingredients and ethanol. The business enterprise also offers pyridine and picolines, cyanopyridines, piperidines, acetyl pyridines, amino pyridines, halo pyridines, pyridine aldehydes, steel complexes, amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines, vitamin B3 and picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight components, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, absolute alcohol, ethanol, biocompost, CO2 and ETO combinations. In addition, it gives direction design, method improvement, technique optimization, and scale-up and business manufacturing of intermediates. Further, the business enterprise gives nutrients, mineral premixes, stress regulator, amino acid, herbal choline, natural non-antibiotic boom promoter and egg pleasant enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, nutrients, agrochemical, consumer, and business clients. The agency was formerly referred to as Jubilant LSI Ltd and changed its name to Jubilant Ingrevia Ltd in October 2020. Jubilant Ingrevia Ltd incorporated in 2019 and is based in Noida, India.

Jubilant Ingrevia Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Jubilant Ingrevia Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	1223	1286	1296	1166	1304	1158	1145	1075	1020	966
Other Income	7	9	9	10	7	7	9	9	9	9
Total Income	1230	1296	1305	1176	1311	1165	1154	1084	1028	975
Total Expenditure	1027	1074	1153	1025	1151	1007	1043	958	902	871
Operating Profit	202	222	152	151	160	158	111	125	126	104
Interest	7	5	6	4	5	7	6	11	13	15
Depreciation	31	30	31	31	31	30	30	32	34	34
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	165	187	115	116	124	122	76	81	80	55
Provision for Tax	54	58	46	36	40	30	23	24	22	17
Profit After Tax	111	129	69	79	84	92	52	58	57	39
Adjustments	-0	-0	-0	0	-0	-0	0	-0	0	0
Profit After Adjustments	111	129	69	79	84	92	52	58	57	39
Adjusted Earnings Per Share	7	8.1	43.1	5	5.3	5.8	3.3	3.6	3.6	2.4

Jubilant Ingrevia Profit & Loss

#(Fig in Cr.)	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	0	684	4949	4773	4206
Other Income	0	3	31	33	36
Total Income	0	687	4981	4806	4241
Total Expenditure	0	567	4118	4226	3774
Operating Profit	-0	120	863	581	466
Interest	0	7	31	22	45
Depreciation	0	22	123	122	130
Exceptional Income / Expenses	0	-13	0	0	0
Profit Before Tax	-0	77	709	437	292
Provision for Tax	0	23	232	129	86
Profit After Tax	-0	54	477	307	206
Adjustments	0	0	0	0	0
Profit After Adjustments	-0	54	477	307	206
Adjusted Earnings Per Share	-3.3	3.4	30	19.3	12.9

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	-4%	0%	0%	0%
Operating Profit CAGR	-33%	0%	0%	0%
PAT CAGR	-36%	0%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	28%	8%	NA%	NA%
ROE Average	12%	13%	10%	10%
ROCE Average	16%	17%	13%	13%

Jubilant Ingrevia Balance Sheet

#(Fig in Cr.)	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	-0	1923	2433	2666
Minority's Interest	0	0	0	0
Borrowings	0	456	100	150
Other Non-Current Liabilities	0	93	197	253
Total Current Liabilities	0	894	1053	1180
Total Liabilities	0	3366	3782	4249
Fixed Assets	0	1805	1798	1846
Other Non-Current Assets	0	137	219	585
Total Current Assets	0	1424	1765	1818
Total Assets	0	3366	3782	4249

Jubilant Ingrevia Cash Flow

#(Fig in Cr.)	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	0	73	38
Cash Flow from Operating Activities	112	453	462
Cash Flow from Investing Activities	-44	-72	-472
Cash Flow from Financing Activities	-72	-418	42
Net Cash Inflow / Outflow	-4	-37	32
Closing Cash & Cash Equivalent	73	38	73

Jubilant Ingrevia Ratios

#	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	-3.32	3.41	29.99	19.34
CEPS(Rs)	-3.32	4.8	37.75	27.03
DPS(Rs)	0	0.35	5	5
Book NAV/Share(Rs)	-2.32	120.73	152.96	167.47
Core EBITDA Margin(%)	0	17.07	16.79	11.45
EBIT Margin(%)	0	12.35	14.93	9.59
Pre Tax Margin(%)	0	11.28	14.31	9.14
PAT Margin (%)	0	7.92	9.62	6.43
Cash Profit Margin (%)	0	11.14	12.11	8.99
ROA(%)	-332	3.23	13.34	7.66
ROE(%)	0	5.65	21.89	12.07
ROCE(%)	0	6.86	28.84	16.01
Receivable days	0	250.55	38.75	41.69
Inventory Days	0	323.99	56	74.31
Payable days	0	342.47	95.87	113.03
PER(x)	0	76.51	15	18.6
Price/Book(x)	0	2.16	2.94	2.15
Dividend Yield(%)	0	0.13	1.11	1.39
EV/Net Sales(x)	0	6.71	1.48	1.26
EV/Core EBITDA(x)	0	38.32	8.49	10.39
Net Sales Growth(%)	0	0	623.45	-3.57
EBIT Growth(%)	0	0	773.36	-38.06
PAT Growth(%)	0	0	776.97	-35.5
EPS Growth(%)	0	202.8	778.68	-35.5
Debt/Equity(x)	0	0.28	0.09	0.15
Current Ratio(x)	0.3	1.59	1.68	1.54
Quick Ratio(x)	0.3	0.91	0.81	0.66
Interest Cover(x)	0	11.56	23.92	21.24
Total Debt/Mcap(x)	0	0.13	0.03	0.07

Jubilant Ingrevia Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	51.03	51.1	51.47	51.47	51.47	51.47	51.47	51.47	51.47	51.47
FII	12.42	11.21	10.19	9.25	8.39	7.73	6.15	6.3	6.35	6.58
DII	0.61	0.67	0.7	2.36	4.89	5.98	6.73	9.18	11.18	13.6
Public	35.95	37.02	37.64	36.92	35.24	34.82	35.65	33.05	30.99	28.34
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	8.13	8.14	8.2	8.2	8.2	8.2	8.2	8.2	8.2	8.2
FII	1.98	1.78	1.62	1.47	1.34	1.23	0.98	1	1.01	1.05
DII	0.1	0.11	0.11	0.38	0.78	0.95	1.07	1.46	1.78	2.17
Public	5.73	5.9	5.99	5.88	5.61	5.55	5.68	5.26	4.94	4.51
Others	0	0	0	0	0	0	0	0	0	0
Total	15.93	15.93	15.93	15.93	15.93	15.93	15.93	15.93	15.93	15.93

Pros

Company is almost debt free.

Cons

Company has a low return on equity of 13% over the last 3 years.
Debtor days have increased from 95.87 to 113.03days.
Stock is trading at 3.1 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.